7th Annual Translational Science Symposium
The Boston University Clinical and Translational Science Institute and The Grayken Center for Addiction co-sponsored the Seventh Annual Translational Research Symposium “In Memory of David C. Seldin, MD, PhD (1957-2015)” on May 3, 2018. The event was held in the Hiebert Lounge, located in the Boston University School of Medicine Instructional Building, and was attended by over 200 guests.
The symposium, entitled “Addiction Medicine 2018: Translational Science at the cutting edge” highlighted several guest speakers who discussed the on-going opioid crisis accompanied by research-based presentations. The symposium also featured 32 e-Poster boards containing various topics relating to Addiction Medicine.
Featured speakers included, Executive Director of the Grayken Center – Michael Botticelli, Dean of the Boston University School of Public Health – Sandro Galea, Commissioner of the Massachusetts Department of Public Health – Monica Bharel, Dean of the Boston University School of Social Work – Jorge Delva, and Director of the Division of Clinical Innovation for the National Center for Advancing Translational Sciences (NCATS) – Michael G. Kurilla.
Keynote speaker and Director of the National Institute on Drug Abuse, Nora D. Volkow, presented in length about the potential relationship of translational science among the opioid crisis. Volkow’s PowerPoint presentation was titled “Addressing the Opioid Crisis: A Key Role for Translational Science.”
Senator Ed Markey attended the symposium, providing the closing remarks about the positive contributions and efforts of the professionals at the Boston University School of Medicine and the Grayken Center on issues involving the opioid crisis and addiction. The Senator reminded those in attendance to encourage those in need to find a pathway to treatment.
For those unable to attend in person, the CTSI held a YouTube livestream that totaled 175 views. On twitter, #AddictionSymposium2018 was posted 161 times, with a unique reach of 236,293 people. Please see below for information from the symposium, including presentation slides and a video playlist.
Dr. Seldin will be remembered for organizing the annual Translational Science Symposium and we are indebted to him for his vision and contributions.
May 3, 2018
Hiebert Lounge, Instructional Building, Boston University School of Medicine
72 East Concord Street, 14th Floor, Boston, MA 02118
Symposium Agenda
Watch AddictionSymposium2018 Playlist
Guest Speakers |
Nora D. Volkow, MD – Keynote Speaker Director, National Institute on Drug Abuse (NIDA) Addressing the Opioid Crisis: A Key Role for Translational Science View PowerPoint Slides |
Senator Ed Markey – Closing Remarks U.S Senator of Massachusetts |
Michael G. Kurilla, MD, PhD – NCATS – Perspective Director, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health NCATS – Perspective |
Kate Walsh, MPH President & CEO, Boston Medical Center |
Karen Antman, MD Provost, Boston University Medical Campus Dean, Boston University School of Medicine |
Michael Botticelli Executive Director, Grayken Center for Addiction |
David M. Center, MD Director, BU CTSI |
Sandro Galea, MD, MPH, DrPH Dean and Robert A. Knox Professor Boston University School of Public Health The Opioid Epidemic in Context: On Mitigating the Epidemic, and Preventing the Next One View PowerPoint Slides |
Monica Bharel, MD, MPH Commissioner of the Massachusetts Department of Public Health; Clinical Assistant Professor BUSM Addressing the Opioid Epidemic Through a Public Health Lens View PowerPoint Slides |
Jorge Delva, PhD, MSW Dean of Boston University School of Social Work The Opioid Epidemic in an Uncertain World: Are People Being Pushed Over the Edge? View PowerPoint Slides |
Sarah M. Bagley, MD Assistant Professor of Medicine BUSM; Clinical Addiction Research & Education (CARE) Unit Faculty Engaging Emerging Adults in Care After Nonfatal Opioid Overdose View PowerPoint Slides |
Jessie M. Gaeta , MD Assistant Professor of Medicine BUSM; Chief Medical Officer, Boston Health Care for the Homeless Program Harm Reduction and Research: Evaluation of SPOT View PowerPoint Slides |
John Renner, MD Professor of Psychiatry; Director Addiction Psychiatry Fellowship; Associate Chief of Psychiatry VA Boston Healthcare System VA’s Response to the Opioid Epidemic. Translational Science in Action View PowerPoint Slides |
Colleen T. LaBelle, MSN, RN-BC, CARN Program Director STATE OBAT; Executive Director MA IntNSA; Clinical Addiction Research & Education (CARE) Unit Faculty New Approaches to Disseminating Treatment: Technology, Low Barrier MAT and Prison Health View PowerPoint Slides |
Marc R. LaRochelle, MD, MPH Assistant Professor of Medicine BUSM; Clinical Addiction Research & Education (CARE) Unit Faculty Touchpoints Prior to Opioid Overdose Death View PowerPoint Slides |
Tae Woo Park, MD, MSc Addiction Psychiatrist, BMC; Assistant Professor of Psychiatry BUSM Benzodiazepine Use in Opioid Agonist Treatment: The Risks and the Benefits View PowerPoint Slides |
Richard Saitz, MD, MPH, FACP, DFASAM Professor BUSM and BUSPH, Chair, Department of Community Health Sciences BUSPH Research on Integrating Addiction and Medical Care at BMC: The First 25 Years View PowerPoint Slides |
Jeffrey H. Samet, MD, MA, MPH Professor of Medicine, Chief, Section of General Internal Medicine BMC, Vice Chair for Public Health, Department of Medicine Workforce Development: BUSM/BMC Addiction Education and Policy Initiatives View PowerPoint Slides |
Stacey Sigmon, PhD Research Associate Professor of Psychology & Psychiatry, University of Vermont; Director, The Chittenden Clinic Interim Buprenorphine Dosing for Reducing Illicit Drug Use and Associated Risks Among Waitlisted Opioid-Dependent Adults View PowerPoint Slides |
Other Distinguished Guests |
Joan Davis Nagel, MD, MPH Medical Officer, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS) |
Government Representatives – TBA |